Do we use the appropriate controls for the identification of informative methylation markers for early cancer detection?

Genome Biology

Volumn 9, Issue 11, 2008, Pages

  Riazalhosseini, Yasser ^a   Hoheisel, Jörg D ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR MARKER;

ARTICLE; BREAST CANCER; CARCINOGENESIS; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; DNA MODIFICATION; EARLY DIAGNOSIS; EPIGENETICS; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; PROGNOSIS; PROMOTER REGION; SENSITIVITY AND SPECIFICITY; BREAST TUMOR; CANCER DIAGNOSIS; FEMALE; GENETICS; LETTER;

BREAST NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; EARLY DETECTION OF CANCER; FEMALE; HUMANS;

EID: 57049131996     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2008-9-11-405     Document Type: Article

References (20)

1. Jones PA Baylin SB The epigenomics of cancer. Cell 2007, 128:683-692. 10.1016/j.cell.2007.01.029 17320506
2. Esteller M Epigenetics in cancer. N Engl J Med 2008, 358:1148-1159. 10.1056/NEJMra072067 18337604
3. Gal-Yam EN Saito Y Egger G Jones PA Cancer epigenetics: Modifications, screening, and therapy. Annu Rev Med 2008, 59:267-280. 10.1146/ annurev.med.59.061606.095816 17937590
4. Hoheisel JD Microarray technology: Beyond transcript profiling and genotype analysis. Nat Rev Genet 2006, 7:200-210. 10.1038/nrg1809 16485019
5. Shames DS Girard L Gao B Sato M Lewis CM Shivapurkar N Jiang A Perou CM Kim YH Pollack JR Fong KM Lam CL Wong M Shyr Y Nanda R Olopade OI Gerald W Euhus DM Shay JW Gazdar AF Minna JD A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies. PLoS Med 2006, 3:e486. 1716188 17194187 10.1371/ journal.pmed.0030486
6. Ordway JM Budiman MA Korshunova Y Maloney RK Bedell JA Citek RW Bacher B Peterson S Rohlfing T Hall J Brown R Lakey N Doerge RW Martienssen RA Leon J McPherson JD Jeddeloh JA Identification of novel high-frequency DNA methylation changes in breast cancer. PLoS ONE 2007, 2:e1314. 2117343 18091988 10.1371/journal.pone.0001314
7. Chung W Kwabi-Addo B Ittmann M Jelinek J Shen L Yu Y Issa JP Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling. PLoS ONE 2008, 3:e2079. 2323612 18446232 10.1371/journal.pone.0002079
8. Lewis CM Cler LR Bu DW Zochbauer-Muller S Milchgrub S Naftalis EZ Leitch AM Minna JD Euhus DM Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk. Clin Cancer Res 2005, 11:166-172. 15671542
9. Holst CR Nuovo GJ Esteller M Chew K Baylin SB Herman JG Tlsty TD Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res 2003, 63:1596-1601. 12670910
10. Yan PS Venkataramu C Ibrahim A Liu JC Shen RZ Diaz NM Centeno B Weber F Leu YW Shapiro CL Eng C Yeatman TJ Huang TH Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. Clin Cancer Res 2006, 12:6626-6636. 10.1158/1078-0432.CCR-06-0467 17121881
11. Euhus DM Bu D Milchgrub S Xie XJ Bian A Leitch AM Lewis CM DNA methylation in benign breast epithelium in relation to age and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2008, 17:1051-1059. 10.1158/1055-9965.EPI-07-2582 18483325
12. Bean GR Bryson AD Pilie PG Goldenberg V Baker JC Jr Ibarra C Brander DM Paisie C Case NR Gauthier M Reynolds PA Dietze E Ostrander J Scott V Wilke LG Yee L Kimler BF Fabian CJ Zalles CM Broadwater G Tlsty TD Seewaldt VL Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ ARF. Clin Cancer Res 2007, 13:6834-6841. 10.1158/1078-0432.CCR-07-0407 18006786
13. Baylin SB Ohm JE Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 2006, 6:107-116. 10.1038/nrc1799 16491070
14. Feinberg AP Ohlsson R Henikoff S The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006, 7:21-33. 10.1038/nrg1748 16369569
15. Giovannucci E Ogino S DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 2005, 97:1317-1319. 16174847
16. Shen L Kondo Y Rosner GL Xiao L Hernandez NS Vilaythong J Houlihan PS Krouse RS Prasad AR Einspahr JG Buckmeier J Alberts DS Hamilton SR Issa JP MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005, 97:1330-1338. 16174854
17. Liang G Wolff EM Chihara Y Pan F Weisenberger D Laird PW Jones PA DNA methylation profile of 1501 loci in bladder cancer shows evidence of a field defect. Proc 99th Annual Meeting Am Ass Cancer Res: 12-16 April 2008; San Diego 2008 Abstract 2625.
18. Ferguson AT Evron E Umbricht CB Pandita TK Chan TA Hermeking H Marks JR Lambers AR Futreal PA Stampfer MR Sukumar S High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc Natl Acad Sci USA 2000, 97:6049-6054. 18556 10811911 10.1073/pnas.100566997
19. Umbricht CB Evron E Gabrielson E Ferguson A Marks J Sukumar S Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer. Oncogene 2001, 20:3348-3353. 10.1038/sj.onc.1204438 11423985
20. Jones PA Martienssen R A blueprint for a human epigenome project: The AACR Human Epigenome Workshop. Cancer Res 2005, 65:11241-11246. 10.1158/ 0008-5472.CAN-05-3865 16357125